Displaying 101 - 120 of 183
A.S. Research, LLC (Synovia)
The marketers of a dietary supplement called Synovia agreed to settle FTC charges by halting the deceptive tactics they allegedly used to mislead consumers into thinking Synovia could treat arthritis and alleviate joint pain. In December 2020, the Commission announced it was returning almost $775,000 to consumers who both the deceptively marketed product.
Agency Information Collection Activities; Proposals, Submissions, and Approvals (Tobacco Reports)
FTC Refunds More Than $110,000 to Consumers Who Bought StimTein Joint Pain Relief Pills
FTC Refunds Almost $3.9 Million to Purchasers of Deceptively Advertised Quell Wearable Pain-Relief Device
FTC and State of Wisconsin Warn Hearing Aid Sellers About Deceptive Stimulus Payment Claims
FTC Order Stops the Marketer of “Thrive” Supplement from Making Baseless Claims It Can Treat, Prevent, or Reduce the Risks from COVID-19
FTC Sending Refund Checks Totaling Almost $149,000 to Consumers Who Bought ReJuvenation “Anti-Aging” Pill
FTC Sending Refund Checks Totaling More Than $470,000 to Consumers Defrauded by Misleading Health Claims for TrueAloe and AloeCran Supplements
FTC Sends Letters Warning 50 More Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Prevent or Treat COVID-19
FTC Alerts Consumers About Nursing Homes and Assisted Living Facilities Taking Stimulus Checks From Medicaid Patients
“Thrive” Supplement Marketer Agrees to Preliminary Order Barring Him from Claiming It Can Treat, Prevent, or Reduce the Risks Associated with COVID-19
Health Center, Inc. Settles FTC Allegations That It Targeted Older Consumers With Deceptive Claims for Health and Wellness Products
Tea Marketer Misled Consumers, Didn’t Adequately Disclose Payments to Well-Known Influencers, FTC Alleges
Statement of the Commission in the Matter of Teami, LLC
Marketers of Pain Relief Device Settle FTC False Advertising Complaint
FTC Sues Publisher for Targeting Seniors With Phony Diabetes Cure and Money Making Schemes
FTC Obtains Preliminary Injunction Halting Online Beauty Product Sellers’ Deceptive “Free Trial” Offers
Nobetes Corp.
In December 2018, officers of a company that marketed and sold Nobetes, a pill they claimed treats diabetes, settled an FTC complaint alleging that the advertising claims for the product are false or unsubstantiated. The order settling the FTC’s complaint prohibits the company and its officers from undertaking future deceptive practices, including making unsubstantiated health claims, misleading consumers about the terms of “free trial” offers, billing consumers without their consent, and other practices related to the use of “expert” endorsements and consumer testimonials. In addition, it requires them to pay money to provide refunds to consumers who bought the product. In August 2019, the FTC returned $60,791 to these consumers.
Displaying 101 - 120 of 183